Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bethesda, MD 20892Phone+1 301-496-1196
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1991
University of Texas Southwestern Medical Center/St Paul Medical CenterResidency, Internal Medicine, 1987 - 1989
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 1986 - 1987
University of Tennessee Health Science Center College of MedicineClass of 1986
Certifications & Licensure
FL State Medical License 1997 - 2026
TX State Medical License 1988 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H.Mohamed A Gouda, Zihan Wei, Jordi Rodon, Michael A Davies, Filip Janku
JCO Precision Oncology. 2025-02-01 - Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C.Mark H O'Hara, Opeyemi Jegede, Mark A Dickson, Angela M DeMichele, Richard Piekarz
Clinical Cancer Research. 2025-01-06 - 1 citationsSelumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.Andrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, Cecilia Tibery, William G Herrick
Nature Medicine. 2025-01-01
Journal Articles
- Effect of Capivasertib in Patients with an AKT1 E17K-Mutated TumorKevin Kalinsky, Edith P Mitchell, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology
Authored Content
- Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
- Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
- Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
Press Mentions
Drug Approved to Help Young Patients Battle a Rare CancerJanuary 2nd, 2023- Slips, Slides: Winter Injuries Can Be SeriousJanuary 2nd, 2023
NIH Clinical Trials Apply Genomics to Chronic Disease ManagementJune 6th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
